Related Experiment Video
Updated: Aug 18, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease
Anissa A Widjaja1, Sivakumar Viswanathan2, Shamini G Shekeran2
1Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore. anissa.widjaja@duke-nus.edu.sg.
Abstract:
The kidney has large regenerative capacity, but this is compromised when kidney damage is excessive and renal tubular epithelial cells (TECs) undergo SNAI1-driven growth arrest. Here we investigate the role of IL11 in TECs, kidney injury and renal repair. IL11 stimulation of TECs induces ERK- and p90RSK-mediated GSK3β inactivation, SNAI1 upregulation and pro-inflammatory gene expression. Mice with acute kidney injury upregulate IL11 in TECs leading to SNAI1 expression and kidney dysfunction, which is not seen in Il11 deleted mice or in mice administered a neutralizing IL11 antibody in either preemptive or treatment modes. In acute kidney injury, anti-TGFβ reduces renal fibrosis but exacerbates inflammation and tubule damage whereas anti-IL11 reduces all pathologies. Mice with TEC-specific deletion of Il11ra1 have reduced pathogenic signaling and are protected from renal injury-induced inflammation, fibrosis, and failure. In a model of chronic kidney disease, anti-IL11 therapy promotes TEC proliferation and parenchymal regeneration, reverses fibroinflammation and restores renal mass and function. These data highlight IL11-induced mesenchymal transition of injured TECs as an important renal pathology and suggest IL11 as a therapeutic target for restoring stalled endogenous regeneration in the diseased kidney.
Insights
Interleukin-11 (IL11) drives kidney dysfunction and hinders repair by causing renal tubular epithelial cells (TECs) to arrest growth. Blocking IL11 promotes kidney regeneration and restores function in disease models.
Area of Science:
- Nephrology
- Cell Biology
- Immunology
Background:
- Kidney damage often impairs the organ's regenerative capacity.
- Renal tubular epithelial cells (TECs) can enter SNAI1-driven growth arrest, hindering repair.
- The role of Interleukin-11 (IL11) in TECs during kidney injury and repair requires further investigation.
Purpose of the Study:
- To investigate the role of IL11 in TECs during kidney injury and repair.
- To determine if IL11 blockade can restore kidney function and regeneration.
Main Methods:
- Studied IL11 stimulation effects on TECs, including signaling pathways and gene expression.
- Utilized mouse models of acute kidney injury (AKI) and chronic kidney disease (CKD).
- Employed IL11 knockout mice, IL11 neutralizing antibodies, and TEC-specific Il11ra1 deletion models.
Main Results:
- IL11 stimulation of TECs induced GSK3β inactivation, SNAI1 upregulation, and inflammation.
- IL11 upregulation in AKI correlated with kidney dysfunction, which was prevented by IL11 deletion or blockade.
- Anti-IL11 therapy, unlike anti-TGFβ, reduced inflammation, fibrosis, and tubule damage in AKI.
- TEC-specific Il11ra1 deletion protected against AKI-induced pathologies.
- Anti-IL11 treatment in CKD models promoted TEC proliferation, regeneration, and restored renal function.
Conclusions:
- IL11 drives TECs towards a pathogenic mesenchymal transition, impairing kidney regeneration.
- IL11 blockade represents a promising therapeutic strategy for promoting kidney repair and treating kidney disease.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction

